A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
about
Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancerDocetaxel-ifosfamide combination in patients with advanced breast cancer failing prior anthracycline-based regimens: results of a phase I-II study.Docetaxel in advanced non-small cell lung cancer.
P2860
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A phase I-II study of docetaxe ...... ced nonsmall cell lung cancer.
@ast
A phase I-II study of docetaxe ...... ced nonsmall cell lung cancer.
@en
type
label
A phase I-II study of docetaxe ...... ced nonsmall cell lung cancer.
@ast
A phase I-II study of docetaxe ...... ced nonsmall cell lung cancer.
@en
prefLabel
A phase I-II study of docetaxe ...... ced nonsmall cell lung cancer.
@ast
A phase I-II study of docetaxe ...... ced nonsmall cell lung cancer.
@en
P2093
P2860
P356
P1476
A phase I-II study of docetaxe ...... nced nonsmall cell lung cancer
@en
P2093
Adimchi Onyenadum
Christos Kosmas
Dimitris Dimitropoulos
Evangelos Sepsas
Maria Vadiaka
Nicolas B Tsavaris
Niki Stavroyianni
Sofia Rokana
Thomas Makatsoris
P2860
P304
P356
10.1002/IJC.10162
P577
2002-03-01T00:00:00Z